In CRC, IL-6 and TNFα participate in most steps of cancer progression, including tumor initiation, proliferation, migration, and angiogenesis (Flores et al., 2012; Wang et al., 2013; Wang and Sun, 2014; West et al., 2015). The gene discussed is TNF; the disease is neoplasm.